Marshall Wace’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,359
| Closed | -$3.6M | – | 2658 |
|
|
2023
Q4 | $3.6M | Buy |
+11,359
| New | +$3.6M | 0.01% | 852 |
|
|
2023
Q1 | – | Sell |
-1,207
| Closed | -$237K | – | 2894 |
|
|
2022
Q4 | $237K | Sell |
1,207
-60,905
| -98% | -$12M | ﹤0.01% | 2060 |
|
|
2022
Q3 | $14M | Buy |
62,112
+11,531
| +23% | +$2.59M | 0.03% | 571 |
|
|
2022
Q2 | $6.4M | Buy |
50,581
+42,821
| +552% | +$5.42M | 0.01% | 1072 |
|
|
2022
Q1 | $983K | Buy |
7,760
+4,560
| +143% | +$578K | ﹤0.01% | 1861 |
|
|
2021
Q4 | $419K | Buy |
+3,200
| New | +$419K | ﹤0.01% | 2238 |
|
|
2021
Q2 | – | Sell |
-45,861
| Closed | -$5.52M | – | 2724 |
|
|
2021
Q1 | $5.52M | Buy |
+45,861
| New | +$5.52M | 0.03% | 706 |
|
|
2020
Q2 | – | Sell |
-1,034
| Closed | -$74K | – | 2006 |
|
|
2020
Q1 | $74K | Buy |
+1,034
| New | +$74K | ﹤0.01% | 1357 |
|